3. Mackowiak PA, LeMaistre CF. Drug fever: a critical reappraisal of convenional concepts. Ann Intern Med. 1987; 106:728-733.
4.
4. Troost RJ, Oranje AP, Lijnen RL, et al. Exfoliative dermatitis due to immunoogically confirmed carbamazepine hypersensitivity. PediatrDermatol. 1996; 13:316-320.
5.
5. Alldredge BK, Knutsen AP, Ferriero D. Antiepileptic drug hypersensitivity syndrome: in vitro and clinical observaions. PediatrNeurol. 1994;10:169-171.
6.
6. Shulman ST, DeInocencioJ, Hirsch R. Kawasaki disease. Pediatr Clin North Am. 1995;42:1205-1222.
7.
7. Fukushige J, Takahashi N, Ueda Y, Ueda K. Incidence and clinical feaures of incomplete Kawasaki disease. Acta Pediatr. 1994;83:1057-1060.
9. Kikuta H, Sakiyama Y, Matsumoto S, et al. Detection of Epstein-Barr virus DNA in cardiac and aortic tissues from chronic, active Epstein-Barr virus infection associated with Kawasaki disease-like coronary artery aneurisms. J Pediatr.1993;123:90-92.
10.
10. Descamps V, Vouscarat F, Laglene S, et al. Human herpesvirus 6 infection asociated with anticonvulsant hyperensitivity syndrome and reactive haemophagocytic syndrome. BrJDeratol. 1997;137:605-608.